Treatment and the treatment process

Treatment of ALL

Acute lymphoblastic leukemia (ALL) is the most common leukemia in children, but it also occurs in adults. This topic explains the phases of ALL treatment and modern methods.

Last updated: 14 October 2026~2 min read

A long road of light across a dark navy landscape passes through four glowing gateways to a calm horizon. — **Figure 1.**ALL treatment is a long road through several phases.

01Short answer

ALL treatment has several phases: induction (to reach remission), consolidation and intensification (to destroy remaining cells), and then long maintenance therapy (usually tablets, 2–3 years in total). Throughout all phases, the central nervous system is protected — most often by giving drugs into the spinal fluid (intrathecal chemotherapy). In Philadelphia chromosome–positive ALL (BCR::ABL1), a tyrosine kinase inhibitor is added. In B-ALL, immunotherapy — blinatumomab, inotuzumab ozogamicin and CAR-T cell therapy — is used especially at relapse or when residual disease (MRD) remains. An allogeneic transplant may be considered when the risk is high.

02Simple explanation

Induction. Several drugs together quickly reduce the leukemia cells.

Consolidation. Extra courses against hidden remaining cells.

Maintenance. A long period of tablets at home with regular blood tests.

Protecting the brain. Leukemia cells can reach the brain and spinal cord, so special prevention is given.

03Scientific explanation

Combination chemotherapy: induction usually uses a steroid (prednisolone or dexamethasone), vincristine, asparaginase and sometimes an anthracycline (NCI, ACS). In maintenance, the main drugs are mercaptopurine and methotrexate.

MRD: measuring residual disease after induction is one of the strongest risk markers and sets treatment intensity.

Targeted and immune treatment: imatinib, dasatinib or ponatinib in Ph+ ALL; in B-ALL, blinatumomab and CAR-T aimed at CD19, and inotuzumab ozogamicin aimed at CD22. Nelarabine may be used in T-ALL.

04What happens in the body?

Children and adults

ALL treatment in children is very successful: in high-income countries about 90% of children survive long term. Results in adults are lower but improving with targeted drugs and immunotherapy. Young adults are often treated with "paediatric-style" protocols.

Protecting the central nervous system

Most drugs do not cross the blood–brain barrier well. So methotrexate or other drugs are given into the spinal fluid by lumbar puncture. Sometimes high-dose systemic chemotherapy is used, and rarely radiotherapy.

A translucent brain and spinal cord on a dark background wrapped in protective teal light. — **Figure 2.**CNS prevention stops leukemia from reaching the brain.

Immunotherapy

Blinatumomab is an antibody that "links" T cells to a leukemia cell. In CAR-T therapy, a person’s own T cells are changed in a laboratory and returned to fight the leukemia. These methods have changed treatment, but they do not suit everyone.

A translucent lymphoblast and an immune cell joined by a glowing Y-shaped antibody bridge. — **Figure 3.**Immunotherapy directs an immune cell to the leukemia cell.

05The ALL treatment path

A simplified general outline.

1InductionReach remission.

2CNS preventionIntrathecal drugs.

3MaintenanceTablets at home.

4Follow-upRegular checks.

RemissionOften achieved.

MRDPlan by risk.

TeamA long road together.

06Phases of ALL treatment

Phase	Length (approx.)	Main goal
Induction	4–6 weeks	Remission
Consolidation / intensification	Several months	Destroy remaining cells
Maintenance	1.5–2.5 years	Prevent relapse
CNS prevention	Throughout	Protect brain and spinal cord
Targeted / immune treatment	When indicated	Ph+, MRD, relapse
Transplant	High risk	Long-term control

* Timings vary by protocol; your doctor sets your plan.

07Key terms

ALL: Acute lymphoblastic leukemia.
Intrathecal: Given into the spinal fluid.
Philadelphia chromosome: A chromosome carrying the BCR::ABL1 fusion gene.
Asparaginase: A drug that deprives leukemia cells of an amino acid they need.
Blinatumomab: An antibody that joins T cells to a leukemia cell.
CAR-T: Treatment with a person’s own modified T cells.

08Key points

ALL treatment is phased and long.
CNS prevention matters.
MRD shapes risk and plan.
A targeted drug is added in Ph+ ALL.
Immunotherapy has widened the options.
Results in children are very good.

09Frequently asked questions

Can I go to school or work during maintenance?

Often yes, with your doctor’s agreement and infection-prevention rules.

Is a lumbar puncture painful?

It is done under local anaesthetic, or brief general anaesthetic in children; a headache can follow.

Why is treatment so long?

Long maintenance therapy clearly lowers the risk of relapse.

Is a transplant always needed?

No, it is considered only for high risk or relapse.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

Can I go to school or work during maintenance?
Is a lumbar puncture painful?
Why is treatment so long?
Is a transplant always needed?

My questions

12Sources

National Cancer Institute (NCI). Adult Acute Lymphoblastic Leukemia Treatment (PDQ) – Patient Version
National Cancer Institute (NCI). Childhood Acute Lymphoblastic Leukemia Treatment (PDQ) – Patient Version
American Cancer Society. Typical Treatment of Acute Lymphocytic Leukemia
Cancer Research UK. Treatment for acute lymphoblastic leukaemia (ALL)
NHS. Acute lymphoblastic leukaemia: Treatment
Leukemia & Lymphoma Society. ALL treatment
MedlinePlus (U.S. National Library of Medicine). Types of chemotherapy
Macmillan Cancer Support. Chemotherapy — what it is, types, treatment and side effects
American Cancer Society. Targeted Therapy
American Cancer Society. Targeted Drug Therapy Side Effects

Medical disclaimerThis information is for educational purposes only and does not replace medical advice.

Last updated: 14 October 2026← Back to the list

Open the interactive site →